Dr. med. Armin Furtwängler is Global Senior Medical Director - Health Care Innovation at Boehringer Ingelheim. His focus areas include New Business Models & Health Care Innovation – not typically associated and expected in a (very) traditional German Pharmaceutical Company. He is Board-Certified in Internal Medicine, Cardiology and Interventional Cardiology, as well as Emergency Medicine. Since 2001, Dr. Furtwängler has been working in Clinical Development and Medical Affairs Roles in the Pharmaceutical Industry. In July 2016, he began a new role as a Global Senior Medical Director – Health Care Innovation within the Boehringer Ingelheim Group of Companies, with responsibilities covering ALL Therapeutic Areas within Boehringer Ingelheim, as an "Intrapreneuer" and "Disruptive Innovator"